Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/06/2007EP1792927A1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
06/06/2007EP1792913A1 Novel secreted and membrane-associated proteins and uses therefor
06/06/2007EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use
06/06/2007EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent
06/06/2007EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes
06/06/2007EP1792899A1 Process for production of optically active amine derivatives
06/06/2007EP1792898A1 Molecular chaperone function regulator
06/06/2007EP1792630A1 Conjugates of amino acids and vitamin B3 for percutaneous delivery of vitamin B3
06/06/2007EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same
06/06/2007EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
06/06/2007EP1792622A1 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
06/06/2007EP1792621A1 Orally administrable heparin derivatives
06/06/2007EP1792620A1 Medicinal composition containing diabetes remedy
06/06/2007EP1792619A1 Beta-sitosterol for treating porcine respiratory disease complex
06/06/2007EP1792618A1 R-mirtazapine for the treatment of pain
06/06/2007EP1792617A1 Treatment of dyskinesia
06/06/2007EP1792616A1 Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia
06/06/2007EP1792615A1 Method of screening for a visceral pain inhibitor
06/06/2007EP1792614A1 Benzo[b]thiophene derivatives
06/06/2007EP1792613A2 Dicationic compounds which selectively recognize G-quadruplex DNA
06/06/2007EP1792611A1 Matrix controlled transdermal system for stable derivatives of ACE inhibitors
06/06/2007EP1792610A2 Sustained release bioadhesive therapeutic systems
06/06/2007EP1792608A2 Composition in the form of an oil-in-water emulsion and its cosmetic uses
06/06/2007EP1791949A2 Methods and materials relating to enhanced production of dopamine neurons
06/06/2007EP1791904A2 Method of treating organophosphorous poisoning
06/06/2007EP1791873A1 New polymorphic form of inulin and uses thereof
06/06/2007EP1791872A1 Biotinylated hexadecasaccharides, preparation and use thereof
06/06/2007EP1791854A2 Methods of treating disorders having a component of mercury toxicity
06/06/2007EP1791844A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments
06/06/2007EP1791841A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
06/06/2007EP1791840A1 Substituted bicyclic imidazo-3-ylamine compounds
06/06/2007EP1791838A2 Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
06/06/2007EP1791837A1 Substituted hydantoins for the treatment of cancer
06/06/2007EP1791836A1 Thiazolinone 2-substituted quinolines
06/06/2007EP1791835A2 Thiazole derivatives having vap-1 inhibitory activity
06/06/2007EP1791833A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases
06/06/2007EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors
06/06/2007EP1791828A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates
06/06/2007EP1791827A1 4-heteroarylmethyl substituted phthalazinone derivatives
06/06/2007EP1791823A1 Antibiotic and method for production thereof
06/06/2007EP1791821A2 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
06/06/2007EP1791818A1 Hydrazone derivatives and their use as beta secretase inhibitors
06/06/2007EP1791817A1 Dpp-iv inhibitors
06/06/2007EP1791815A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists
06/06/2007EP1791813A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
06/06/2007EP1791812A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
06/06/2007EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
06/06/2007EP1791809A1 Substituted aniline derivatives
06/06/2007EP1791807A1 Therapeutic diphenyl ether ligands
06/06/2007EP1791806A2 Amine compounds and inhibiting neurotransmitter reuptake
06/06/2007EP1791600A1 Combination of organic compounds
06/06/2007EP1791599A1 Combination of a 5-ht(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine
06/06/2007EP1791598A1 Use of metronidazole combined with azelaic acid for the treatment of rosacea
06/06/2007EP1791597A2 Carbonyl compound-containing drug and the use thereof
06/06/2007EP1791568A2 Therapeutic uses of inhibitors of rtp801
06/06/2007EP1791567A2 Chemically modified oligonucleotides
06/06/2007EP1791566A2 Product and process for inhibition of biofilm development
06/06/2007EP1791550A2 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions
06/06/2007EP1791549A2 Sulfonylethyl phosphorodiamidates for use in the treatment of cancer
06/06/2007EP1791548A1 Compositions and methods for smoking cessation
06/06/2007EP1791547A1 Oral formulations of paricalcitol
06/06/2007EP1791546A2 Long acting injectable crystal formulations of estradiol metabolites and methods of using same
06/06/2007EP1791545A1 Prostaglandin derivatives for treating gastrointestinal disorder
06/06/2007EP1791544A2 Quinazoline derivatives as metabolically inert antifolate compounds
06/06/2007EP1791543A2 Triazolophthalazines
06/06/2007EP1791542A1 Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
06/06/2007EP1791541A2 Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds
06/06/2007EP1791540A2 Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
06/06/2007EP1791539A1 Process to prepare camptothecin derivatives
06/06/2007EP1791538A1 Roflumilast and syk inhibitor combination and methods of use thereof
06/06/2007EP1791537A1 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
06/06/2007EP1791536A1 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus
06/06/2007EP1791535A2 Novel tellurium compounds and their use as immunomodulators
06/06/2007EP1791534A1 Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent
06/06/2007EP1791531A1 Paroxetine formulations
06/06/2007EP1791528A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide
06/06/2007EP1791526A2 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
06/06/2007EP1791525A1 Liposomal compositions of glucocorticoid and glucocorticoid derivatives
06/06/2007EP1791522A1 Dermally applicable formulations for treating skin diseases in animals
06/06/2007EP1791521A2 Methods of administering water-soluble prodrugs of propofol
06/06/2007EP1791423A1 Compositions and methods for the management of hyperproliferative dermatological conditions
06/06/2007EP1699459B1 Method for treatment of multiple sclerosis
06/06/2007EP1684768A4 Methods of treating eczema
06/06/2007EP1682606B1 Anion-binding polymers and uses thereof
06/06/2007EP1619962B1 Composition for oral administration containing capsaicinoids
06/06/2007EP1613313B1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
06/06/2007EP1613297B1 Therapeutic patch with polysiloxane matrix comprising capsaicin
06/06/2007EP1558221B1 Dosage form that is safeguarded from abuse
06/06/2007EP1542666B1 Modafinil pharmaceutical compositions
06/06/2007EP1517683B1 Sustained release tablet containing indapamide
06/06/2007EP1496894A4 Angiogenesis inhibitors
06/06/2007EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
06/06/2007EP1487998B1 Methods for diagnosing and treating schizophrenia
06/06/2007EP1427287B1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
06/06/2007EP1423389B1 Pyrazolo-pyridines for the treatment of herpes infections
06/06/2007EP1423108B1 C-2' methylated derivatives of paclitaxel for use as antitumour agents
06/06/2007EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
06/06/2007EP1406637B1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
1 ... 3724 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 3735 3736 3737 3738 3739 3740 3741 3742 3743 3744 ... 7860